990 results on '"Muzykantov, Vladimir"'
Search Results
2. Anaerobic Lactate Production Is Associated With Decreased Microcirculatory Blood Flow and Decreased Mitochondrial Respiration Following Cardiovascular Surgery With Cardiopulmonary Bypass
3. Nanocarriers' repartitioning of drugs between blood subcompartments as a mechanism of improving pharmacokinetics, safety, and efficacy
4. Controlling spatial distribution of functional lipids in a supported lipid bilayer prepared from vesicles
5. Physiologically based modeling of LNP-mediated delivery of mRNA in the vascular system
6. Targeting lipid nanoparticles to the blood-brain barrier to ameliorate acute ischemic stroke
7. Low postoperative perfused vessel density is associated with increased soluble endothelial cell adhesion molecules during circulatory shock after cardiac surgery.
8. Abstract 16198: Targeting Lipid Nanoparticles to the Blood Brain Barrier to Ameliorate Acute Ischemic Stroke
9. Targeted drug delivery to the brain endothelium dominates over passive delivery via vascular leak in experimental intracerebral hemorrhage
10. Targeting of nanoparticles to the cerebral vasculature after traumatic brain injury
11. Marginated neutrophils in the lungs effectively compete for nanoparticles targeted to the endothelium, serving as a part of the reticuloendothelial system
12. Added to pre-existing inflammation, mRNA-lipid nanoparticles induce inflammation exacerbation (IE)
13. Supramolecular arrangement of protein in nanoparticle structures predicts nanoparticle tropism for neutrophils in acute lung inflammation
14. Topical nitroglycerin to detect reversible microcirculatory dysfunction in patients with circulatory shock after cardiovascular surgery: an observational study
15. Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs
16. Erythrocyte-driven immunization via biomimicry of their natural antigen-presenting function
17. Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood–brain barrier
18. Pathologically stiff erythrocytes impede contraction of blood clots
19. Systemic tumour suppression via the preferential accumulation of erythrocyte-anchored chemokine-encapsulating nanoparticles in lung metastases
20. Physicochemical Targeting of Lipid Nanoparticles to the Lungs Induces Clotting: Mechanisms and Solutions.
21. Mechanisms and Barriers in Nanomedicine: Progress in the Field and Future Directions.
22. Differential Impact In Vivo of Pf4-ΔCre-Mediated and Gp1ba-ΔCre-Mediated Depletion of Cyclooxygenase-1 in Platelets in Mice.
23. A combination of physicochemical tropism and affinity moiety targeting of lipid nanoparticles enhances organ targeting
24. Effective Prevention of Arterial Thrombosis with Albumin-Thrombin Inhibitor Conjugates
25. Target-mediated exposure enhancement: a previously unexplored limit of TMDD
26. Combining vascular targeting and the local first pass provides 100-fold higher uptake of ICAM-1-targeted vs untargeted nanocarriers in the inflamed brain
27. PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake
28. Spatially controlled assembly of affinity ligand and enzyme cargo enables targeting ferritin nanocarriers to caveolae
29. Engineered Dual Antioxidant Enzyme Complexes Targeting ICAM-1 on Brain Endothelium Reduce Brain Injury-Associated Neuroinflammation.
30. Ferritin-based drug delivery systems: Hybrid nanocarriers for vascular immunotargeting
31. Targeting superoxide dismutase to endothelial caveolae profoundly alleviates inflammation caused by endotoxin
32. 1-Cys Peroxiredoxin Overexpression Protects Cells against Phospholipid Peroxidation-Mediated Membrane Damage
33. Mechanisms that determine nanocarrier targeting to healthy versus inflamed lung regions
34. CRISPR/Cas9-Mediated Genetic Engineering of Hybridomas for Creation of Antibodies that Allow for Site-Specific Conjugation
35. Targeting lipid nanoparticles to the blood brain barrier to ameliorate acute ischemic stroke
36. Streptavidin Facilitates Internalization and Pulmonary Targeting of an Anti-Endothelial Cell Antibody (Platelet-Endothelial Cell Adhesion Molecule 1): A Strategy for Vascular Immunotargeting of Drugs
37. Modulation of Angiotensin-Converting Enzyme in Cultured Human Vascular Endothelial Cells
38. Targeting therapeutics to endothelium: are we there yet?
39. Breast tumors interfere with endothelial TRAIL at the premetastatic niche to promote cancer cell seeding
40. Low Postoperative Perfused Vessel Density is Associated with Increased Soluble Endothelial Cell Adhesion Molecules During Circulatory Shock after Cardiac Surgery
41. Immunotargeting of Antioxidant Enzymes to the Pulmonary Endothelium
42. Size and targeting to PECAM vs ICAM control endothelial delivery, internalization and protective effect of multimolecular SOD conjugates
43. Molecular engineering of high affinity single-chain antibody fragment for endothelial targeting of proteins and nanocarriers in rodents and humans
44. Targeted endothelial nanomedicine for common acute pathological conditions
45. Flow shear stress differentially regulates endothelial uptake of nanocarriers targeted to distinct epitopes of PECAM-1
46. Targeting Pulmonary Endothelium
47. Biological Barriers for Drug Targeting
48. Protocol for the MicroRESUS study: The impact of circulatory shock and resuscitation on microcirculatory function and mitochondrial respiration after cardiovascular surgery
49. Red Blood Cell Anchoring Enables Targeted Transduction and Re‐Administration of AAV‐Mediated Gene Therapy
50. Endothelial targeting of nanocarriers loaded with antioxidant enzymes for protection against vascular oxidative stress and inflammation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.